The connection between CD8+ T cells and the microbiota also provides a new interpretation to the recent observation that the relative abundance of particular SCFA-producing microbiota constituents is strictly associated with responsiveness to PD-1 blockade in cancer patients [2, 4, 5]. This evidence concerns the gene CD8A and cancer.